These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 36003019)

  • 1. Armodafinil to reduce the sleepiness related side-effects of sleep restriction therapy being used to treat insomnia disorder: An open label clinical trial pilot study compared with historical controls.
    Judge DJ; Miller CB; Bartlett DJ; Jomaa I; Wong KKW; Saini B; Semsarian CR; Espie CA; Kyle SD; Grunstein RR; Yee BJ; Marshall NS
    J Sleep Res; 2023 Feb; 32(1):e13699. PubMed ID: 36003019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of armodafinil and cognitive behavior therapy for insomnia on sleep continuity and daytime sleepiness in cancer survivors.
    Garland SN; Roscoe JA; Heckler CE; Barilla H; Gehrman P; Findley JC; Peoples AR; Morrow GR; Kamen C; Perlis ML
    Sleep Med; 2016 Apr; 20():18-24. PubMed ID: 27318221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The long-term tolerability and efficacy of armodafinil in patients with excessive sleepiness associated with treated obstructive sleep apnea, shift work disorder, or narcolepsy: an open-label extension study.
    Black JE; Hull SG; Tiller J; Yang R; Harsh JR
    J Clin Sleep Med; 2010 Oct; 6(5):458-66. PubMed ID: 20957846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Armodafinil for the treatment of excessive sleepiness associated with mild or moderate closed traumatic brain injury: a 12-week, randomized, double-blind study followed by a 12-month open-label extension.
    Menn SJ; Yang R; Lankford A
    J Clin Sleep Med; 2014 Nov; 10(11):1181-91. PubMed ID: 25325609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Indirect treatment comparison of solriamfetol, modafinil, and armodafinil for excessive daytime sleepiness in obstructive sleep apnea.
    Ronnebaum S; Bron M; Patel D; Menno D; Bujanover S; Kratochvil D; Lucas E; Stepnowsky C
    J Clin Sleep Med; 2021 Dec; 17(12):2543-2555. PubMed ID: 34402784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A double-blind, placebo-controlled study of armodafinil for excessive sleepiness in patients with treated obstructive sleep apnea and comorbid depression.
    Krystal AD; Harsh JR; Yang R; Rippon GA; Lankford DA
    J Clin Psychiatry; 2010 Jan; 71(1):32-40. PubMed ID: 20051221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of armodafinil in the treatment of residual excessive sleepiness associated with obstructive sleep apnea/hypopnea syndrome: a 12-week, multicenter, double-blind, randomized, placebo-controlled study in nCPAP-adherent adults.
    Roth T; White D; Schmidt-Nowara W; Wesnes KA; Niebler G; Arora S; Black J
    Clin Ther; 2006 May; 28(5):689-706. PubMed ID: 16861091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sleep restriction therapy for insomnia is associated with reduced objective total sleep time, increased daytime somnolence, and objectively impaired vigilance: implications for the clinical management of insomnia disorder.
    Kyle SD; Miller CB; Rogers Z; Siriwardena AN; Macmahon KM; Espie CA
    Sleep; 2014 Feb; 37(2):229-37. PubMed ID: 24497651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tolerability and efficacy of armodafinil in naïve patients with excessive sleepiness associated with obstructive sleep apnea, shift work disorder, or narcolepsy: a 12-month, open-label, flexible-dose study with an extension period.
    Schwartz JR; Khan A; McCall WV; Weintraub J; Tiller J
    J Clin Sleep Med; 2010 Oct; 6(5):450-7. PubMed ID: 20957845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Double-Blind, Placebo-Controlled, Crossover Study of Armodafinil Treatment of Daytime Sleepiness Associated With Treated Nocturia.
    Krystal AD; Preud'homme XA
    Sleep; 2017 Jan; 40(1):. PubMed ID: 28364461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of modafinil and cognitive behavior therapy on sleep continuity in patients with primary insomnia.
    Perlis ML; Smith MT; Orff H; Enright T; Nowakowski S; Jungquist C; Plotkin K
    Sleep; 2004 Jun; 27(4):715-25. PubMed ID: 15283007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive behavioral therapy for insomnia, but not armodafinil, improves fatigue in cancer survivors with insomnia: a randomized placebo-controlled trial.
    Heckler CE; Garland SN; Peoples AR; Perlis ML; Shayne M; Morrow GR; Kamen C; Hoefler J; Roscoe JA
    Support Care Cancer; 2016 May; 24(5):2059-2066. PubMed ID: 26542272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Daytime sleepiness, driving performance, reaction time and inhibitory control during sleep restriction therapy for Chronic Insomnia Disorder.
    Whittall H; Pillion M; Gradisar M
    Sleep Med; 2018 May; 45():44-48. PubMed ID: 29680427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjunct armodafinil improves wakefulness and memory in obstructive sleep apnea/hypopnea syndrome.
    Hirshkowitz M; Black JE; Wesnes K; Niebler G; Arora S; Roth T
    Respir Med; 2007 Mar; 101(3):616-27. PubMed ID: 16908126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of cognitive behavioral therapy for insomnia and armodafinil on quality of life in cancer survivors: a randomized placebo-controlled trial.
    Peoples AR; Garland SN; Perlis ML; Savard J; Heckler CE; Kamen CS; Ryan JL; Mustian KM; Janelsins MC; Peppone LJ; Morrow GR; Roscoe JA
    J Cancer Surviv; 2017 Jun; 11(3):401-409. PubMed ID: 28105576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of Modafinil and Armodafinil in Patients With Obstructive Sleep Apnea: A Meta-analysis of Randomized Controlled Trials.
    Kuan YC; Wu D; Huang KW; Chi NF; Hu CJ; Chung CC; Tam KW; Huang YH
    Clin Ther; 2016 Apr; 38(4):874-88. PubMed ID: 26923035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic exposure to armodafinil and its tolerability in healthy elderly versus young men: an open-label, multiple-dose, parallel-group study.
    Darwish M; Kirby M; Hellriegel ET; Yang R; Robertson P
    Drugs Aging; 2011 Feb; 28(2):139-50. PubMed ID: 21275439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Wakefulness-Promoting Agents on Sleepiness in Patients with Sleep Apnea Treated with CPAP: A Meta-Analysis.
    Sukhal S; Khalid M; Tulaimat A
    J Clin Sleep Med; 2015 Oct; 11(10):1179-86. PubMed ID: 25979103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of excessive sleepiness in sleep restriction therapy and cognitive behavioral therapy for insomnia: a randomized controlled trial.
    Cheng P; Kalmbach D; Fellman-Couture C; Arnedt JT; Cuamatzi-Castelan A; Drake CL
    J Clin Sleep Med; 2020 Feb; 16(2):193-198. PubMed ID: 31992407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modafinil/armodafinil in obstructive sleep apnoea: a systematic review and meta-analysis.
    Chapman JL; Vakulin A; Hedner J; Yee BJ; Marshall NS
    Eur Respir J; 2016 May; 47(5):1420-8. PubMed ID: 26846828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.